发明申请
US20120108492A1 LIGAND-SPECIFIC NON-ANTIBODY COMPOUNDS THAT INHIBIT CR2 ACTIVATION AND METHODS OF USE THEREOF
审中-公开
抑制CR2活化的配体特异性非抗体化合物及其使用方法
- 专利标题： LIGAND-SPECIFIC NON-ANTIBODY COMPOUNDS THAT INHIBIT CR2 ACTIVATION AND METHODS OF USE THEREOF
- 专利标题（中）： 抑制CR2活化的配体特异性非抗体化合物及其使用方法
-
申请号： US13119706申请日： 2009-09-18
-
公开(公告)号： US20120108492A1公开(公告)日： 2012-05-03
- 发明人: V. Michael Holers , Jonathan P. Hannan , James Kovacs
- 申请人： V. Michael Holers , Jonathan P. Hannan , James Kovacs
- 申请人地址： US CO Denver
- 专利权人： The Regents of the University of Colorado
- 当前专利权人： The Regents of the University of Colorado
- 当前专利权人地址： US CO Denver
- 国际申请： PCT/US09/57580 WO 20090918
- 主分类号： A61K38/02
- IPC分类号： A61K38/02 ; C07K7/06 ; A61P31/22 ; C07K2/00
摘要：
The present invention describes a novel non-antibody ligand-specific compound that selectively binds to a complement receptor type 2 (CR2) protein, a ligand thereof, or both, wherein the compound competitively inhibits CR2 ligand's binding to a CR2 protein in a standard assay. The present invention also describes compositions and methods of use thereof.
信息查询
IPC分类:
